Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Collapsing glomerulopathy.

Mamdouh Albaqumi1, Timothy J Soos, Laura Barisoni

  • 1Division of Nephrology, NYU School of Medicine, Smilow Research Center, 522 First Avenue, New York, NY 10016, USA.

Journal of the American Society of Nephrology : JASN
|August 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Length of Follow-Up Time Needed for Stable eGFR Slope Estimation in Glomerular Disease.

Kidney360·2026
Same author

Hypoxia inducible factor network reflects kidney disease progression in diabetes and sodium-glucose co-transporters inhibition.

Signal transduction and targeted therapy·2026
Same author

Shared multicellular injury programs of acute and chronic kidney disease enable mechanistic patient stratification.

medRxiv : the preprint server for health sciences·2026
Same author

Glomerular Transcriptome Analysis Reveals Endothelial Disturbances in Patients With Idiopathic Nephrotic Syndrome.

Kidney medicine·2026
Same author

Case Series of Histopathological Findings in Chronic Kidney Disease: Insights From the Kidney Precision Medicine Project.

Kidney medicine·2026
Same author

Wnt-associated DKK3 in keratinocytes mediates radiation-induced hyperplasia, dermatitis and skin fibrosis.

Signal transduction and targeted therapy·2026
Same journal

Variants to Functions to Therapeutic Strategies Toward Genomically Informed Care for Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Personalizing Cardio-Kidney-Metabolic Therapy: Closer But Not There Yet.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Autosomal Dominant Tubulointerstitial Kidney Disease: My Kingdom for a Biomarker.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Beyond the Margin: Improving Noninferiority Trials of Kidney Transplant Immunosuppression.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Parathyroid Hormone Receptor 1 Facilitates Cyst Growth in Genetic Models of Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Alanyl-tRNA Synthetase 1 and Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
See all related articles

Collapsing glomerulopathy (CG) is a major cause of kidney failure. Recent research into its genetic causes, disease models, and new treatments offers hope for better outcomes in managing this condition.

Area of Science:

  • Nephrology
  • Glomerular Diseases
  • Renal Pathology

Background:

  • Collapsing glomerulopathy (CG) is a distinct pattern of kidney injury.
  • It is a significant cause of end-stage renal disease (ESRD).
  • CG is associated with rapid loss of kidney function and poor response to standard treatments.

Purpose of the Study:

  • To review recent advances in understanding the pathogenesis of CG.
  • To highlight progress in the development of new therapeutic strategies for CG.
  • To provide an updated perspective on CG research.

Main Methods:

  • Literature review of recent research on collapsing glomerulopathy.
  • Analysis of studies on genetic susceptibility, murine models, and preclinical therapies.

Related Experiment Videos

  • Synthesis of current knowledge on CG pathogenesis and treatment.

    • Main Results:

    • Identification of susceptibility genes for CG.
    • Development of increased murine models for CG research.
    • Promising preclinical data for novel therapeutic interventions.

    Conclusions:

    • CG is increasingly recognized as a distinct and significant renal disease.
    • Advances in genetic research and preclinical studies are improving the outlook for CG.
    • Future research holds promise for improved understanding and treatment of collapsing glomerulopathy.